APA aipamena

He, X., Qu, F., Zhou, F., Zhou, X., Chen, Y., Guo, X., . . . Xing, J. (2016). High leukocyte mtDNA content contributes to poor prognosis through ROS-mediated immunosuppression in hepatocellular carcinoma patients. Oncotarget.

Chicago Style aipamena

He, Xianli, et al. "High Leukocyte MtDNA Content Contributes to Poor Prognosis Through ROS-mediated Immunosuppression in Hepatocellular Carcinoma Patients." Oncotarget 2016.

MLA aipamena

He, Xianli, et al. "High Leukocyte MtDNA Content Contributes to Poor Prognosis Through ROS-mediated Immunosuppression in Hepatocellular Carcinoma Patients." Oncotarget 2016.